Augmentation of the anticancer activity of CYT997 in human prostate cancer by inhibiting Src activity
Abstract Background Abnormalities of tubulin polymerization and microtubule assembly are often seen in cancer, which make them very suitable targets for the development of therapeutic approach against rapidly dividing and aggressive cancer cells. CYT997 is a novel microtubule-disrupting agent with a...
Main Authors: | Yong Teng, Yafei Cai, Wenhu Pi, Lixia Gao, Chloe Shay |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2017-06-01
|
Series: | Journal of Hematology & Oncology |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s13045-017-0485-0 |
Similar Items
-
CYT997(Lexibulin) induces apoptosis and autophagy through the activation of mutually reinforced ER stress and ROS in osteosarcoma
by: Zongyi Wang, et al.
Published: (2019-01-01) -
Mitochondrial ROS accumulation inhibiting JAK2/STAT3 pathway is a critical modulator of CYT997-induced autophagy and apoptosis in gastric cancer
by: Ya Cao, et al.
Published: (2020-06-01) -
Structure and Characterization of a Covalent Inhibitor of Src Kinase
by: Deepak Gurbani, et al.
Published: (2020-05-01) -
Treatment of Recurrent Intracranial Hemangiopericytoma with SRC-Related Tyrosine Kinase Targeted Therapy: A Case Report
by: Katherine B. Peters, et al.
Published: (2010-04-01) -
Monitoring Src status after dasatinib treatment in HER2+ breast cancer with 89Zr-trastuzumab PET imaging
by: Brooke N. McKnight, et al.
Published: (2018-10-01)